PHARMAXIS PTY LTD has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Canada, EPO (European Patent Office) and New Zealand. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEORPHYS, ALIHODZIC SULEJMAN and HEIDELBERG PHARMA HOLDING GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | New Zealand | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Israel | 1 | |
#7 | Singapore | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Sugars | |
#3 | Special acyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Robertson Alan | 5 |
#2 | Eschler Bart Michael | 5 |
#3 | March Darren Ray | 5 |
#4 | Cowden William Butler | 5 |
#5 | Bartell Gavin James | 5 |
#6 | Gerba Sendaba | 4 |
#7 | Eschler Bart | 4 |
#8 | Cowden William | 4 |
#9 | Charlton Brett | 4 |
#10 | March Darren | 4 |
Publication | Filing date | Title |
---|---|---|
AU2004240938A1 | Mannose-6-phosphonate compounds for the treatment of inflammatory diseases | |
CA2415214A1 | Phosphotetrahydropyran compounds |